181 related articles for article (PubMed ID: 692625)
1. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis.
Graze K; Spiler IJ; Tashjian AH; Melvin KE; Cervi-Skinner S; Gagel RF; Miller HH; Wolfe HJ; DeLellis RA; Leape L; Feldman ZT; Reichlin S
N Engl J Med; 1978 Nov; 299(18):980-5. PubMed ID: 692625
[TBL] [Abstract][Full Text] [Related]
2. Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report.
Gagel RF; Melvin KE; Tashjian AH; Miller HH; Feldman ZT; Wolfe HJ; DeLellis RA; Cerviskinner S; Reichlin S
Trans Assoc Am Physicians; 1975; 88():177-91. PubMed ID: 1224435
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
4. Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery.
Lips CJ; Leo JR; Berends MJ; Minder WH; Blok AP; Geerdink RA; Hackeng WH; Roelofs JM; Vasen HF; Vette JK
Henry Ford Hosp Med J; 1987; 35(2-3):133-8. PubMed ID: 2891645
[No Abstract] [Full Text] [Related]
5. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
6. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
7. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
[TBL] [Abstract][Full Text] [Related]
8. Results of a screening program for multiple endocrine neoplasia type II.
Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
[TBL] [Abstract][Full Text] [Related]
9. [Early recognition of C-cell carcinoma by family screening (author's transl)].
Wahl RA; Schmidt-Gayk H; Cordes H; Meybier H; Tschahargane C
Dtsch Med Wochenschr; 1981 Oct; 106(42):1377-80. PubMed ID: 7285815
[TBL] [Abstract][Full Text] [Related]
10. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
[No Abstract] [Full Text] [Related]
12. [Screening for the familial form of medullary cancer of the thyroid].
Allannic H
Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis and treatment of medullary thyroid carcinoma.
Wells SA; Dilley WG; Farndon JA; Leight GS; Baylin SB
Arch Intern Med; 1985 Jul; 145(7):1248-52. PubMed ID: 4015274
[No Abstract] [Full Text] [Related]
14. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
Rays; 2000; 25(2):257-66. PubMed ID: 11370543
[TBL] [Abstract][Full Text] [Related]
16. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.
Gagel RF; Tashjian AH; Cummings T; Papathanasopoulos N; Kaplan MM; DeLellis RA; Wolfe HJ; Reichlin S
N Engl J Med; 1988 Feb; 318(8):478-84. PubMed ID: 2893259
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
18. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
19. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
20. [MEN 2A syndrome: report of a family].
Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
